Microtia Clinical Trials
Conditions / Microtia
Delta Trials tracks 26 clinical trials for Microtia in its publicly accessible dataset. Among the listed trials, 4 open for participant enrollment and 7 trials have reached completion. This research is carried out at 37 clinical sites around the world. An additional 15 trials have active registrations outside the recruiting and completed categories. Since 2020, 5 trials have been terminated before reaching their primary endpoint. This dataset is refreshed continuously as trial statuses are updated on ClinicalTrials.gov, capturing longitudinal changes in the research landscape.
Trial Status
26
Total Trials
4
Recruiting
7
Completed
15
Other Active
5
Terminated since 2020
37
Study Locations
Browse by location (37 total)
- New York, United States 3 trialsAll trials in New York, United States
- Shanghai, China 3 trialsAll trials in Shanghai, China
- Maastricht, Netherlands 2 trialsAll trials in Maastricht, Netherlands
- Seattle, United States 2 trialsAll trials in Seattle, United States
- Los Angeles, United States 2 trialsAll trials in Los Angeles, United States
- Philadelphia, United States 2 trialsAll trials in Philadelphia, United States
- Chapel Hill, United States 2 trialsAll trials in Chapel Hill, United States
- San Antonio, United States 1 trialAll trials in San Antonio, United States
- Cincinnati, United States 1 trialAll trials in Cincinnati, United States
- São Paulo, Brazil 1 trialAll trials in São Paulo, Brazil
- São Paulo, Brazil 1 trialAll trials in São Paulo, Brazil
- São Paulo, Brazil 1 trialAll trials in São Paulo, Brazil
- São Paulo, Brazil 1 trialAll trials in São Paulo, Brazil
- São Paulo, Brazil 1 trialAll trials in São Paulo, Brazil
- São Paulo, Brazil 1 trialAll trials in São Paulo, Brazil
- São Paulo, Brazil 1 trialAll trials in São Paulo, Brazil
- São Paulo, Brazil 1 trialAll trials in São Paulo, Brazil
- Tegucigalpa, Honduras 1 trialAll trials in Tegucigalpa, Honduras
- Recife, Brazil 1 trialAll trials in Recife, Brazil
- Beijing, China 1 trialAll trials in Beijing, China